Pf
Non verificato

Pfizer Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute
27/10/2026
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Industria
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma
1.00
26/10/2026
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Industria
Pfizer’s TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting
1.00
24/10/2026
Scienza
Infanzia
Medicina - Varie
Biotecnologia
Salute
Vetrine/Shopping
Farmaceutica
Sanità
Industria
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
1.00
14/10/2026
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
Pfizer Showcases Clinical Advancements Across Infectious Diseases at IDWeek 2026
1.00
07/10/2026
Industria
Oncologia
Igiene alimentare
Salute
Sanità
Farmaceutica
Biotecnologia
Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer
1.00
06/10/2026
Titoli e azioni
Salute
Sanità
Scienza
Farmaceutica
Biotecnologia
Pfizer Declares Fourth-Quarter 2026 Dividend
1.00
01/10/2026
Eventi
Industria
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Sanità
Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study
1.00
28/09/2026
Eventi
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Pfizer Advances Today’s Cancer Care and Tomorrow's Potential Breakthroughs at ESMO
1.00
22/09/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Pfizer Invites Public to View and Listen to Webcast of November 3 Conference Call with Analysts
1.00
15/09/2026
Salute
Medicina - Varie
Sanità
Scienza
Farmaceutica
Eventi
Web e Social Network
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
1.00

Recapiti

Social Media

Seguaci
0
Compatibilità
0